Filling the Future with Innovation
Costa Mesa, CA – September 11, 2025 – Pyramid Pharma Services proudly hosted the grand opening of its new Groninger sterile fill-finish line at its Costa Mesa headquarters, marking a significant milestone in the company’s 37-year history. Themed “Filling the Future with Innovation,” the event welcomed more than 80 guests, including industry partners, clients, local officials, and community leaders, underscoring Pyramid’s continued investment in cutting-edge pharmaceutical manufacturing.
A Warm Welcome and Community Recognition
The celebration began with opening remarks from CEO Dirk Lange and Brooke Marshall, VP of Business Development, followed by special recognition from David Haithcock, President & CEO of the Costa Mesa Chamber of Commerce, who highlighted Pyramid’s important role in the local business community for nearly four decades. Beyond advancing pharmaceutical innovation, Pyramid has been a cornerstone of the Costa Mesa economy—providing stable, high-quality jobs, contributing to the growth of California’s thriving life sciences sector, and supporting countless families across the region. This legacy of consistency and impact underscores Pyramid’s reputation as both a trusted CDMO partner and a reliable employer dedicated to the prosperity of its community.
Ribbon cutting ceremony
A ceremonial ribbon-cutting brought together Pyramid’s leadership, partners, and local officials for a group photo, symbolizing the start of a new chapter in the company’s sterile manufacturing capabilities. The participation of CFO Jan Miller and COO Doris Michor on stage was a testament of their commitment to the long-term success of Pyramid, ensuring the company remains financially strong, operationally agile, and well-positioned to meet the evolving needs of biotech and pharmaceutical innovators.
Innovation on Display
Attendees experienced the new Groninger line firsthand as CEO, Dirk Lange personally led each tour, showcasing the facility’s advanced capabilities and taking the time to answer guest questions directly. The new integrated filling line will support larger batch production, shorten turnaround times, and enhance scalability, empowering our clients to advance therapies from early-stage clinical trials to full commercial production.
Industry Insights from Keynote Leaders
The event featured keynote presentations from leading life sciences experts:
- CRB Group: Saurav Khanna, Process Specialist and Chris Humphrey, Senior Director & Office Leader, shared insights on aseptic facility design and pharmaceutical process engineering.
- Kymanox: Nathan Blazei, MEng, CQA, RAC, spoke on quality management systems, validation, and regulatory readiness.
- Jeff Yuen & Associates, Inc.: Jeff Yuen, MPH, MBA, highlighted compliance and regulatory perspectives, drawing on his 30+ years in public health and FDA leadership.
- Stevanato Group: Valeria Leone, Pharm.D., discussed innovations in pharma business development and global market access.
A Celebration of Milestones
The grand opening coincided with Pyramid’s 37th anniversary and 10 years of commercial manufacturing. These milestones reflect the company’s legacy of reliability and forward-looking growth, underscoring a track record of consistent performance.
They reaffirm Pyramid’s role as both a trusted, long-standing partner and an agile CDMO prepared to guide clients from clinical development through commercial supply with uncompromising quality and service.
Following a champagne reception, guests continued the celebration with an off-site networking event and light dinner at the Balboa Bay Club in Newport Beach, strengthening connections across the life sciences community.
Building for the Future
The addition of the Groninger fill-finish line reinforces Pyramid’s position as a long term CDMO partner, expanding its sterile manufacturing capacity to better serve clients with speed, scalability, and quality.
“This investment represents more than new equipment—it represents our commitment to helping clients deliver life-changing therapies to patients faster and more reliably than ever before,” said CEO Dirk Lange.
To learn more about our role in advancing direct product manufacturing, visit Pyramid Pharma Services or contact up at : info@pyramidlabs.com
About Pyramid Pharma Services
Pyramid Pharma Services is a full-service CDMO with deep expertise in many parenteral modalities. From early development through commercial-scale manufacturing, Pyramid provides the technical, regulatory, and scientific capabilities needed to prepare complex therapies in safe, patient-ready formats. By combining expertise with flexible partnerships, we help pharma and biotech companies advance therapies quickly, reliably, and to the highest quality standards.